Pharmacotherapy for Neuropsychiatric Symptoms in Frontotemporal Dementia
The DOI matches its Crossref record; 204 of the 205 references it cites were found in a registry or an index.
Abstract
Despite significant progress in the understanding of the frontotemporal dementias (FTDs), there remains no disease-modifying treatment for these conditions, and limited effective symptomatic treatment. Behavioural variant frontotemporal dementia (bvFTD) is the most common FTD syndrome, and is characterized by severe impairments in behaviour, personality and cognition. Neuropsychiatric symptoms are common features of bvFTD but are present in the other FTD syndromes. Current treatment strategies therefore focus on ameliorating the neuropsychiatric features. Here we review the rationale for current treatments related to each of the main neuropsychiatric symptoms forming the diagnostic criteria for bvFTD relevant to all FTD subtypes, and two additional symptoms not currently part of the diagnostic criteria: lack of insight and psychosis. Given the paucity of effective treatments for these symptoms, we highlight how contributing mechanisms delineated in cognitive neuroscience may inform future approaches to clinical trials and more precise symptomatic treatments for FTDs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A number of small drug trials have also been conducted to treat neuropsychiatric symptoms in frontotemporal dementia 122 and dementia with Lewy bodies 123 , but with limited evidence of success.”
From Mental health care for older adults: recent advances and new directions in clinical practice and research (2022) · cites this paper as [122]
In the citing paper
“There is currently no approved drug treatment for frontotemporal dementia. The focus of treatment is on the management of neuropsychiatric symptoms. The symptoms targeted have been apathy, disinhibition, obsessive‐compulsive and hoarding behaviors, loss of empathy and prosocial behavior, loss of insight, and psychosis, but results thus far have not been conclusive for the various interventions”
From Mental health care for older adults: recent advances and new directions in clinical practice and research (2022) · cites this paper as [122]
In the citing paper
“Drugs to modulate the serotonergic and dopaminergic systems are used off‐label to treat these symptoms, but with modest success 122 .”
From Mental health care for older adults: recent advances and new directions in clinical practice and research (2022) · cites this paper as [122]
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
How do you feel — now? The anterior insula and human awareness
(Bud) Craig, A. D. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2555 · Cited by 6,657
Cognitive and emotional influences in anterior cingulate cortex
Bush, G., Luu, P., & Posner, M. I. (2000) · Trends in Cognitive Sciences · doi:10.1016/s1364-6613(00)01483-2 · Cited by 6,259
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221
Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047
Predictive reward signal of dopamine neurons
Schultz, W. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.80.1.1 · Cited by 4,564
Hollmann, M., & Heinemann, S. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.000335 · Cited by 3,975
Oxytocin increases trust in humans
Kosfeld, M., Heinrichs, M., Zak, P. J., Fischbacher, U., & Fehr, E. (2005) · Nature · doi:10.1038/nature03701 · Cited by 3,690
Dopamine, learning and motivation.
Wise, R. A. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1406 · Cited by 3,379
Contributions of anterior cingulate cortex to behaviour
Devinsky, O., Morrell, M. J., & Vogt, B. A. (1995) · Brain · doi:10.1093/brain/118.1.279 · Cited by 3,377
Research works printed but not linked: 2
- Finger EC. Frontotemporal dementias. Contin Minneap Minn. 2016;22:464–89.
- Babinski J. Anosognosie. Paris: Revue Neurologique; 1918.
Cited by
Reynolds, C. F., Jeste, D. V., Sachdev, P. S., & Blazer, D. G. (2022) · World Psychiatry · doi:10.1002/wps.20996 · Cited by 465
Santos‐García, I., Rodríguez‐Cueto, C., Villegas, P., Piscitelli, F., Lauritano, A., Shen, C.-K. J., Marzo, V. D., Fernández‐Ruíz, J., & de Lago, E. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02792-z · Cited by 15
Occupational Therapy Interventions in Patients with Frontotemporal Dementia: A Systematic Review
Vlotinou, P., Tsiakiri, A., Detsaridou, G., Nikova, A. S., Tsiptsios, D., Vadikolias, Κ., & Aggelousis, N. (2023) · Medical Sciences · doi:10.3390/medsci11040071 · Cited by 12
GABAergic modulation of beta power enhances motor adaptation in frontotemporal lobar degeneration
Hughes, L. E., Adams, N., Rouse, M. A., Naessens, M., Shaw, A. D., Murley, A. G., Cope, T., Holland, N., Nesbitt, D., Street, D., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14531 · Cited by 9
Gonzalo‐Consuegra, C., Santos‐García, I., García‐Toscano, L., Martín-Baquero, R., Rodríguez‐Cueto, C., Wittwer, M., Dżygiel, P., Grether, U., de Lago, E., & Fernández‐Ruíz, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116473 · Cited by 9
Metadata
- Authors
- Le, C., & Finger, E.
- Affiliations
- Western University (CA)
- Corresponding author
- Finger, Elizabeth
- ORCID
- Finger, Elizabeth
- Venue
- CNS Drugs
- Published
- 2021-08-24
- Volume
- 35
- Issue
- 10
- Pages
- 1081-1096
- ISSN
- 1172-7047 (ISSN-L)
- 1179-1934
- OpenAlex
- W3194250079
- Cited by
- 26
- References
- 205
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 14 · 2023: 3 · 2022: 4
- FWCI
- 0.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- CNS Drugs (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institute of Health Research (363926)
- Physicians' Services Incorporated Foundation (Mid-career Clinical Research Award)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- frontotemporal dementia, behavioral variant frontotemporal dementia, neuropsychiatric symptoms, pharmacotherapy, lack of insight, psychosis, symptomatic treatment, disease-modifying therapy
- MeSH terms
- Mental Disorders, Humans, Inhibition, Psychological, Neuropsychological Tests, Antipsychotic Agents, Dopamine Agents, Randomized Controlled Trials as Topic, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacotherapy for Neuropsychiatric Symptoms in Frontotemporal Dementia. https://app.cochat.ai/papers/10.1007/s40263-021-00854-5
- The paper
- Le, C., & Finger, E. (2021). Pharmacotherapy for Neuropsychiatric Symptoms in Frontotemporal Dementia. CNS Drugs. https://doi.org/10.1007/s40263-021-00854-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.